Concept Life Science welcomes Michael Mellor-Clark as new Chief Commercial Officer (CCO)

We are pleased to announce the appointment of Mick as our new Chief Commercial Officer (CCO). Mick joins the team from Pathoquest, bringing with him a wealth of experience and expertise in the CRO industry.

In his previous role at Pathoquest, Mick demonstrated a remarkable ability to drive growth and innovation, making significant contributions to the company's success. With a proven track record of strategic leadership and business development, Mick is poised to play a key role in our continued expansion and market leadership.

As Chief Commercial Officer, Mick will be responsible for shaping our commercial strategy, fostering key partnerships, and driving revenue growth.

"I am excited to join Concept Life Sciences and contribute to its continued growth and success, "said Mick. "I look forward to working with the team to build on the company's strong foundation and drive innovation in the CRO space. For example, at this weeks’ CHI Drug Discovery, we are launching BioPALS. This AI-powered, lean and versatile hit identification platform allows our customers to progress from concept to clinic with more speed and certainty.”

Mick's appointment comes at a pivotal time as the company continues to expand its presence in the market and pursue new opportunities for growth.

Read Mick’s full biography here : Concept Life Sciences

Authored by Ben Cliff CEO

‍